Eric d'Esparbes

2022 - BIORA THERAPEUTICS

In 2022, Eric d'Esparbes earned a total compensation of $1.7M as EVP, Chief Financial Officer at BIORA THERAPEUTICS, a 5% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$146,003
Option Awards$576,680
Salary$486,130
Stock Awards$450,998
Other$19,773
Total$1,679,584

d'Esparbes received $576.7K in option awards, accounting for 34% of the total pay in 2022.

d'Esparbes also received $146K in non-equity incentive plan, $486.1K in salary, $451K in stock awards and $19.8K in other compensation.

Rankings

In 2022, Eric d'Esparbes' compensation ranked 2,025th out of 5,753 executives tracked by ExecPay. In other words, d'Esparbes earned more than 64.8% of executives.

ClassificationRankingPercentile
All
2,025
out of 5,753
65th
Division
Manufacturing
1,086
out of 3,133
65th
Major group
Chemicals And Allied Products
464
out of 1,419
67th
Industry group
Drugs
426
out of 1,320
68th
Industry
Pharmaceutical Preparations
310
out of 966
68th
Source: SEC filing on April 27, 2023.

d'Esparbes' colleagues

We found two more compensation records of executives who worked with Eric d'Esparbes at BIORA THERAPEUTICS in 2022.

2022

Adi Mohanty

BIORA THERAPEUTICS

Chief Executive Officer

2022

Clarke Neumann

BIORA THERAPEUTICS

General Counsel

News

You may also like